Royal Philips Electronics has unveiled its InnerCool RTx Endovascular System, which in a closed-loop system offers sophisticated complete body temperature modulation therapy.
The system can quickly increase and decrease a patient¡¦s body temperature.
The RTx warms and cools patients using an integrated temperature sensor catheter placed right below the heart. The system modulates the patient¡¦s body temperature even without introducing fluids. This approach allows accurate temperature control of the body. The system can be effectively used for therapeutic hypothermia patients. Besides the RTX, the company provides the InnerCool STx Surface Pad System for warming and cooling, which is an easy-to-use and cost-effective solution meant for non-invasive temperature modulation therapy.
Developments in technology and clinical research are increasing the possible applications in which the company¡¦s new system can assist improve outcomes. Philips¡¦ new products meet the needs of hospitals, clinical practices and patients.
The General Manager and Senior Vice President of Cardiac Care, Philips HealthCare Mike Miller opined that the Philips InnerCool RTx Endovascular System is an advanced temperature modulation therapeutic solution. Moreover, due to its fast warming and cooling rates, the system can find applications in multiple clinical areas.
The RTx comes with a programmable console having a sensitive touch screen interface. The product can be utilized with both the Accutrol Catheter and a standard catheter. The average warming rates and cooling rates for the RTx are 2-3„aC/h and 4-5„aC/h, respectively.